Skip to content

Compared with 3D and 2D cavity mirror cavity mirror minimally invasive surgical treatment of esophageal prospective, randomized, controlled multicenter study

Compared with 3D and 2D cavity mirror cavity mirror minimally invasive surgical treatment of esophageal prospective, randomized, controlled multicenter study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089561
Enrollment
Unknown
Registered
2024-09-11
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Group A:Mckeown esophagectomy with 3D thoracoscopic and laparoscopic esophagectomy (right thoracic esophageal mobilization + upper abdominal gastric mobilization + neck anastomosis)
Group B:Mckeown esophagectomy with 2D thoracoscopic and laparoscopic esophagectomy (right thoracic esophageal mobilization + upper abdominal gastric mobilization + neck anastomosis)

Sponsors

Cancer Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) into the group signed a written informed consent before; 2) aged 18 to 80 years old; 3) pathology and imaging diagnosis; 4) cT1-2 nomo or cT1-3 nxm0 feasible radical resection of thoracic segment esophageal cancer patients; 5) ECOG score: 0 ~ 1; 6) the expected survival time is more than 6 months; 7) no major organ dysfunction: bone marrow reserve, liver and kidney function were evaluated to tolerate surgery; 8) subjects were willing to join in this study, good adherence, cooperate with the security and survival period of follow-up.

Exclusion criteria

Exclusion criteria: 1) the subjects had a history or concurrent history of other malignant tumors; 2) has a history of chest surgery; 3) need emergency surgery treatment of bleeding, perforation, obstruction, etc.; 4) severe cardiopulmonary dysfunction of liver and kidney researchers think that the person is not suitable for surgery; 5) patients with clinical symptoms of chest water, need therapeutic puncture and drainage; 6) subjects are participating in another clinical study or less than 1 month from the end of their previous clinical study; 7) subjects were known to have a psychiatric drug abuse, alcohol or illicit drugs; 8) The subjects were unable or did not agree to pay for the examination and treatment at their own expense; 9) researchers think that should be left out in this study, the researchers determine, for example, the subjects have other factors that may result in this study were forced to midway termination, such as, other serious disease (including mental illness) need to merge treatment, there are serious abnormal laboratory examination, accompanied by factors such as family or society, will affect the safety of the subjects, or information and the collection of the sample.

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative week voice hoarse;

Secondary

MeasureTime frame
The number of lymph nodes dissected;The operation time;Intraoperative blood loss;R0 resection rate;The incidence of anastomotic leakage;The hospitalization time;

Countries

China

Contacts

Public ContactYong Li

Cancer Hospital, Chinese Academy of Medical Sciences

liyongdoctor@126.com+86 181 0128 1977

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026